Effect of three herbal extracts on NO and PGE2 production by activated mouse macrophage-like cells

In Vivo

Volumn 23, Issue 4, 2009, Pages 537-544

  Chu, Qing ^a,b   Hashimoto, Ken ^b   Satoh, Kazue ^c   Wang, Qintao ^a   Sakagami, Hiroshi ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Anti inflammatory activity; COX 2; Herbal extract; iNOS; NO; PGE2; RAW264.7 cells

Indexed keywords

ANGELICA SINENSIS EXTRACT; ARACHIDONIC ACID; CHINESE DRUG; CORNUS OFFICINALIS EXTRACT; CYCLOOXYGENASE 2; DRYNARIA BARONII EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE HERB; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRYNARIA BARONII; ENZYME INHIBITION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION;

EID: 67650992088     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sun JS, Thériault BL and Anderson GI: The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity. Am J Chin Med 32: 737-753, 2004.
2. Jeong JC, Yoon CH, Jeong CW, Lee YC, Chang YC and Kim CH: Inhibitory activity of Drynariae rhizoma extracts on cathepsin having bone resorption activity. Immunopharmacol Immunotoxicol 26: 373-385, 2004.
3. Shi QZ, Wang H and Xu ZL: Influence of Angelica sinenisis injection on expression level of adherent molecule and proliferating cycle of bone marrow cells in irradiated mice. Chin J Radiol Med Protect 26: 358-360, 2006 (in Chinese).
4. Jia M, Yang TH, Yao XJ, Meng JR and Mei QB: Anti-oxidative effect of Angelica polysaccharide sulphate. J Chin Med Mater 30: 185-188, 2007 (in Chinese).
5. Zhao SY, Hu SB, Wu HL, TANG Y and Liu J: Studies on extraction and isolation of bacteriostatic active composition from Fructus corui. J Northwest A & F Univ (Nat Sci Ed) 35: 223-226, 2007 (in Chinese).
6. Hsu JH, Wu YC, Liu IM and Cheng JT: Release of acetylcholine to raise insulin secretion in Wistar rats by oleanolic acid, one of the active principles contained in Cornus officinalis. Neurosci Lett 404: 112-116, 2006.
7. Zhang LT, Ren LM and Wen JK: Studies on antiarrhythmic portion in Cornus officinalis extract. Chin Tradit Drugs 32: 1004-1007, 2001 (in Chinese).
8. Xu H, Shen J, Liu H, Shi Y, Li L and Wei M: Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol 84: 1267-1273, 2006. (Pubitemid 46707375)
9. Nawa Y, Endo J and Ohta T: The inhibitory effect of the components of Cornus officinalis on melanogenesis. J Cosmet Sci 58: 505-517, 2007.
10. Chu Q, Satoh K, Kanamoto T, Terakubo S, Nakashima H, Wang Q and Sakagami H: Antitumor potential of three herbal extracts against human oral squamous cell lines. Anticancer Res 29: in press, 2009.
11. Fu GX, Li JM, Zhou Y and Zhao SP: Anti-inflammatory and immune suppressive effects of Cornus officinals glucosides in rats. Chin J Microb Immunol 27: 316-320, 2007 (in Chinese). (Pubitemid 351828260)
12. Cai CS, Xiao P, Zhang Y, Zhao XJ and Lin AZ: Effect of Gusuibu Zonghuangtong on level of TNF-α and IL-6 in macrophagocyte. Orthopedic Journal of China 14: 1185-1187, 2006 (in Chinese).
13. Hu HJ, Hang BQ and Wang PS: Anti-inflammatory effect of radix Angelica sinensis. China J Chin Mater Med 16: 684-686, 1991 (in Chinese).
14. Ralph R and Nakoinz I: Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol 119: 950-954, 1977.
15. Murakami A and Ohigashi H: Cancer-preventive anti - oxidants that attenuate free radical generation by inflammatory cell. Biol Chem 387: 387-392, 2006.
16. Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, Feinberg MW, Aikawa M and Libby P: Prostaglandin E receptor type 4-assocaited protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 283: 9692-9703, 2008.
17. Takahashi J, Sekine T, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, Hashimoto K, Satoh K, Motohashi N and Sakagami H: Inhibition of NO production in LPS-stimulated mouse macrophage-like cells by trihaloacetylazulene derivatives. Anticancer Res 28: 171-178, 2008. (Pubitemid 351362898)
18. Sakagami H, Kishino K, Amano O, Kanda Y, Kunii S, Yokote Y, Oizumi H and Oizumi T: Cell death induced by nutritional starvation in mouse macrophage-like RAW264.7 cells. Anticancer Res 29: 343-348, 2009.
19. 2 production by mouse macrophage-like cells. In Vivo 20: 491-498, 2006. (Pubitemid 44184105)
20. Armour KE, Van TH, Grabowski PS, Reid DM and Ralston SH: Evidence for apathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14: 2137-2142, 1999. (Pubitemid 30026963)
21. Mungrue IN, Bredt DS, Stewart DJ and Husain M: From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand 179: 123-135, 2003.
22. Kröncke KD, Fehsel K and Kolb-Bachofen V: Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156, 1998. (Pubitemid 28352831)
23. Okiji T, Morita I, Kobayashi C, Sunada I and Murota S: Arachidonic acid metabolism in normal and experimentally inflamed rat dental pulp. Arch Oral Biol 32: 723-727, 1987.
24. Cohen JS, Reader A, Fertel R, Beck M and Meyers WJ: A radioimmunoassay determination of the concentrations of prostaglandins E2 and F2alpha in painful and asymptomatic human dental pulps. J Endod 11: 330-335, 1985.
25. Okiji T, Morita I, Sunada I and Murota S: Involvement of arachidonic acid metabolites in increases in vascular permeability in experimental dental pulpal inflammation in the rat. Arch Oral Biol 34: 523-528, 1989.
26. Odau S, Gabler C, Holder C and Einspanier R: Differential expression of cyclooxygenase 1 and cyclooxygenase 2 in the bovine oviduct. J Endocrinol 191: 263-274, 2006. (Pubitemid 44756528)
27. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69: 3-58, 2002.
28. 2 family. Prog Lipid Res 45: 487-510, 2006.
29. O'Banion MK, Winn VD and Young DA: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 89: 4888-4892, 1992.
30. Mancini JA, Blood K, Guay J, Gordon R, Claveau D, Chan CC and Riendeau D: Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J Biol Chem 276: 4569-4575, 2001. (Pubitemid 37371541)
31. Jakobsson PJ, Thorén S, Morgenstern R and Samuelsson B: Identification of human prostaglandin E synthase: amicrosomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220-7226, 1999. (Pubitemid 29299642)
32. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M, Jakobsson PJ and Crofford LJ: Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 167: 469-473, 2001. (Pubitemid 32567813)
33. Kim SF, Huri DA and Snyder SH: Inducible nitric oxide synthase binds S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970, 2005.
34. Suzuki F, Okayasu H, Tashiro M, Hashimoto K, Yokote Y, Akahane K, Hongo S and Sakagami H: Effect of lignins and their precursors on nitric oxide, citrulline and asparagine production by mouse macrophage-like Raw 264.7 cells. Anticancer Res 22: 2719-2724, 2002. (Pubitemid 36069303)
35. Calabrese EJ: Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ Pollut 138: 379-412, 2005.
36. Cook RC and Calabrese EJ: The importance of hormesis to public health. Environ Health perspectives 114: 1631-1635, 2006.